Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.

New head of oncology research hopes to build on recent advances, explore new therapeutic approaches and beat certain cancers for good.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.

Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.

Phil Gotwals talks about his vision for the future of business development for research.